NYSE:TMO - Thermo Fisher Scientific Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$250.83 -1.66 (-0.66 %)
(As of 02/20/2019 02:19 AM ET)
Previous Close$252.49
Today's Range$250.6901 - $252.21
52-Week Range$199.85 - $253.91
Volume1.10 million shs
Average Volume1.88 million shs
Market Capitalization$100.98 billion
P/E Ratio22.56
Dividend Yield0.27%
Beta1.14
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
CUSIP88355610
Phone781-622-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.36 billion
Cash Flow$17.0749 per share
Book Value$68.52 per share

Profitability

Net Income$2.94 billion

Miscellaneous

Employees70,000
Market Cap$100.98 billion
OptionableOptionable

Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Thursday, November 8th. Investors of record on Monday, December 17th will be paid a dividend of $0.17 per share on Tuesday, January 15th. This represents a $0.68 annualized dividend and a yield of 0.27%. The ex-dividend date is Friday, December 14th. View Thermo Fisher Scientific's Dividend History.

How will Thermo Fisher Scientific's stock buyback program work?

Thermo Fisher Scientific announced that its Board of Directors has approved a share buyback plan on Friday, September 7th 2018, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 2.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its shares are undervalued.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) posted its quarterly earnings results on Wednesday, January, 30th. The medical research company reported $3.25 EPS for the quarter, beating the consensus estimate of $3.19 by $0.06. The medical research company earned $6.51 billion during the quarter, compared to analyst estimates of $6.26 billion. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. The company's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.79 EPS. View Thermo Fisher Scientific's Earnings History.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, April 24th 2019. View Earnings Estimates for Thermo Fisher Scientific.

What price target have analysts set for TMO?

11 brokerages have issued 1-year price objectives for Thermo Fisher Scientific's stock. Their predictions range from $255.00 to $300.00. On average, they expect Thermo Fisher Scientific's share price to reach $277.8889 in the next year. This suggests a possible upside of 10.8% from the stock's current price. View Analyst Price Targets for Thermo Fisher Scientific.

What is the consensus analysts' recommendation for Thermo Fisher Scientific?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 2 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Thermo Fisher Scientific.

Has Thermo Fisher Scientific been receiving favorable news coverage?

Media stories about TMO stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Thermo Fisher Scientific earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave media coverage about the medical research company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 51)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 52)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 56)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 53)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 52)

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.50%), Oregon Public Employees Retirement Fund (4.86%), Massachusetts Financial Services Co. MA (4.61%), Geode Capital Management LLC (1.22%), Northern Trust Corp (1.09%) and Bank of New York Mellon Corp (0.79%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald, Tyler Jacks and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Which institutional investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Nordea Investment Management AB, Findlay Park Partners LLP, Orbimed Advisors LLC, Diamond Hill Capital Management Inc., New York State Common Retirement Fund, Sound Shore Management Inc. CT and Foresters Investment Management Company Inc.. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include C Martin Harris, Gregory J Herrema, Marc N Casper, Patrick M Durbin, Stephen Williamson, Tyler Jacks and William G Parrett. View Insider Buying and Selling for Thermo Fisher Scientific.

Which institutional investors are buying Thermo Fisher Scientific stock?

TMO stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Cantillon Capital Management LLC, Geode Capital Management LLC, Prudential Financial Inc., Partner Fund Management L.P., Bank of Nova Scotia and Polar Capital LLP. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $250.83.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $100.98 billion and generates $24.36 billion in revenue each year. The medical research company earns $2.94 billion in net income (profit) each year or $11.12 on an earnings per share basis. Thermo Fisher Scientific employs 70,000 workers across the globe.

What is Thermo Fisher Scientific's official website?

The official website for Thermo Fisher Scientific is http://www.thermofisher.com.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]


MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  665 (Vote Outperform)
Underperform Votes:  295 (Vote Underperform)
Total Votes:  960
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe TMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel